Future prospect of "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients".

导出 LinkOut

翻译打印收藏纠错

第一作者： Yong-Bo,Kang

第一单位： Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Jinzhong 030600, Shanxi Province, China657151276@qq.com.

作者： Yong-Bo,Kang ^[1] ; Yue,Cai ^[2]

作者单位： Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Jinzhong 030600, Shanxi Province, China657151276@qq.com. ^[1] Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Jinzhong 030600, Shanxi Province, China. ^[2]

关键词 Faecal microbiota transplantation Gut microbiome Hepatocellular carcinoma Immune checkpoint inhibitor resistance Immunotherapy Probiotics Prognosis

主题词癌, 肝细胞(Carcinoma, Hepatocellular);人类(Humans);免疫疗法(Immunotherapy);肝肿瘤(Liver Neoplasms)

DOI 10.3748/wjg.v28.i20.2248

PMID 35721889

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

World journal of gastroenterology

2022年28卷20期

2248-2250页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Future prospect of "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients".

World journal of gastroenterology

相似文献

World journal of gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Future prospect of "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients".

World journal of gastroenterology

相似文献

World journal of gastroenterology

相关期刊

检索历史清除